These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 31172637)

  • 1. The never-ending story of CIED infection prevention: Shall we WRAP-IT and go?
    Biffi M
    J Cardiovasc Electrophysiol; 2019 Aug; 30(8):1191-1196. PubMed ID: 31172637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for cardiac implantable electronic device infection: a systematic review and meta-analysis.
    Polyzos KA; Konstantelias AA; Falagas ME
    Europace; 2015 May; 17(5):767-77. PubMed ID: 25926473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-Effectiveness of an Antibacterial Envelope for Cardiac Implantable Electronic Device Infection Prevention in the US Healthcare System From the WRAP-IT Trial.
    Wilkoff BL; Boriani G; Mittal S; Poole JE; Kennergren C; Corey GR; Krahn AD; Schloss EJ; Gallastegui JL; Pickett RA; Evonich RF; Roark SF; Sorrentino DM; Sholevar DP; Cronin EM; Berman BJ; Riggio DW; Khan HH; Silver MT; Collier J; Eldadah Z; Holbrook R; Lande JD; Lexcen DR; Seshadri S; Tarakji KG
    Circ Arrhythm Electrophysiol; 2020 Oct; 13(10):e008503. PubMed ID: 32915063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibacterial Envelope Is Associated With Low Infection Rates After Implantable Cardioverter-Defibrillator and Cardiac Resynchronization Therapy Device Replacement: Results of the Citadel and Centurion Studies.
    Henrikson CA; Sohail MR; Acosta H; Johnson EE; Rosenthal L; Pachulski R; Dan D; Paladino W; Khairallah FS; Gleed K; Hanna I; Cheng A; Lexcen DR; Simons GR
    JACC Clin Electrophysiol; 2017 Oct; 3(10):1158-1167. PubMed ID: 29759500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The World-wide Randomized Antibiotic Envelope Infection Prevention (WRAP-IT) trial: Long-term follow-up.
    Mittal S; Wilkoff BL; Kennergren C; Poole JE; Corey R; Bracke FA; Curnis A; Addo K; Martinez-Arraras J; Issa ZF; Redpath C; Moubarak J; Khelae SK; Boersma LVA; Korantzopoulos P; Krueger J; Lande JD; Morss GM; Seshadri S; Tarakji KG
    Heart Rhythm; 2020 Jul; 17(7):1115-1122. PubMed ID: 32087357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infection control in implantation of cardiac implantable electronic devices: current evidence, controversial points, and unresolved issues.
    Korantzopoulos P; Sideris S; Dilaveris P; Gatzoulis K; Goudevenos JA
    Europace; 2016 Apr; 18(4):473-8. PubMed ID: 26516219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical practice and implementation of guidelines for the prevention, diagnosis and management of cardiac implantable electronic device infections: results of a worldwide survey under the auspices of the European Heart Rhythm Association.
    Traykov V; Bongiorni MG; Boriani G; Burri H; Costa R; Dagres N; Deharo JC; Epstein LM; Erba PA; Snygg-Martin U; Nielsen JC; Poole JE; Saghy L; Starck C; Strathmore N; Blomström-Lundqvist C
    Europace; 2019 Aug; 21(8):1270-1279. PubMed ID: 31209483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibacterial Envelope to Prevent Cardiac Implantable Device Infection.
    Tarakji KG; Mittal S; Kennergren C; Corey R; Poole JE; Schloss E; Gallastegui J; Pickett RA; Evonich R; Philippon F; McComb JM; Roark SF; Sorrentino D; Sholevar D; Cronin E; Berman B; Riggio D; Biffi M; Khan H; Silver MT; Collier J; Eldadah Z; Wright DJ; Lande JD; Lexcen DR; Cheng A; Wilkoff BL;
    N Engl J Med; 2019 May; 380(20):1895-1905. PubMed ID: 30883056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How European centres diagnose, treat, and prevent CIED infections: results of an European Heart Rhythm Association survey.
    Bongiorni MG; Marinskis G; Lip GY; Svendsen JH; Dobreanu D; Blomström-Lundqvist C;
    Europace; 2012 Nov; 14(11):1666-9. PubMed ID: 23104858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Cardiac Implantable Electronic Device Infection: A Clinical and Economic Analysis of the WRAP-IT Trial.
    Wilkoff BL; Boriani G; Mittal S; Poole JE; Kennergren C; Corey GR; Love JC; Augostini R; Faerestrand S; Wiggins SS; Healey JS; Holbrook R; Lande JD; Lexcen DR; Willey S; Tarakji KG;
    Circ Arrhythm Electrophysiol; 2020 May; 13(5):e008280. PubMed ID: 32281393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk Factors for CIED Infection After Secondary Procedures: Insights From the WRAP-IT Trial.
    Tarakji KG; Krahn AD; Poole JE; Mittal S; Kennergren C; Biffi M; Korantzopoulos P; Dallaglio PD; Lexcen DR; Lande JD; Hilleren G; Holbrook R; Wilkoff BL
    JACC Clin Electrophysiol; 2022 Jan; 8(1):101-111. PubMed ID: 34600848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Worldwide Randomized Antibiotic EnveloPe Infection PrevenTion Trial (WRAP-IT).
    Tarakji KG; Mittal S; Kennergren C; Corey R; Poole J; Stromberg K; Lexcen DR; Wilkoff BL
    Am Heart J; 2016 Oct; 180():12-21. PubMed ID: 27659878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized Trial of Stand-Alone Use of the Antimicrobial Envelope in High-Risk Cardiac Device Patients.
    Ellis CR; Greenspon AJ; Andriulli JA; Gould PA; Carillo RG; Kolek MJ; Donegan R; Amaral AP; Mittal S
    Circ Arrhythm Electrophysiol; 2023 May; 16(5):e011740. PubMed ID: 36960716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic impact of introducing TYRX amongst patients with heart failure and reduced ejection fraction undergoing implanted cardiac device procedures: a retrospective model based cost analysis.
    Burnhope E; Rodriguez-Guadarrama Y; Waring M; Guilder A; Malhotra B; Razavi R; Rinaldi CA; Pennington M; Carr-White G
    J Med Econ; 2019 May; 22(5):464-470. PubMed ID: 30744444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention, Diagnosis, and Treatment of Cardiac Implantable Electronic Device Infections.
    Leung S; Danik S
    Curr Cardiol Rep; 2016 Jun; 18(6):58. PubMed ID: 27147510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of the antibacterial envelope to prevent cardiac implantable electronic device infection in a high-risk population.
    Chaudhry U; Borgquist R; Smith JG; Mörtsell D
    Europace; 2022 Dec; 24(12):1973-1980. PubMed ID: 35989511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiotic prophylaxis based on individual infective risk stratification in cardiac implantable electronic device: the PRACTICE study.
    Malagù M; Vitali F; Brieda A; Cimaglia P; De Raffele M; Tazzari E; Musolino C; Balla C; Serenelli M; Cultrera R; Rapezzi C; Bertini M
    Europace; 2022 Mar; 24(3):413-420. PubMed ID: 34487163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of healthcare claims to validate the Prevention of Arrhythmia Device Infection Trial cardiac implantable electronic device infection risk score.
    Ahmed FZ; Blomström-Lundqvist C; Bloom H; Cooper C; Ellis C; Goette A; Greenspon AJ; Love CJ; Johansen JB; Philippon F; Tarakji KG; Holbrook R; Sherfesee L; Xia Y; Seshadri S; Lexcen DR; Krahn AD
    Europace; 2021 Sep; 23(9):1446-1455. PubMed ID: 33755136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mortality and cost associated with cardiovascular implantable electronic device infections.
    Sohail MR; Henrikson CA; Braid-Forbes MJ; Forbes KF; Lerner DJ
    Arch Intern Med; 2011 Nov; 171(20):1821-8. PubMed ID: 21911623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health and Economic Outcomes Associated with Use of an Antimicrobial Envelope as a Standard of Care for Cardiac Implantable Electronic Device Implantation.
    Shariff N; Eby E; Adelstein E; Jain S; Shalaby A; Saba S; Wang NC; Schwartzman D
    J Cardiovasc Electrophysiol; 2015 Jul; 26(7):783-9. PubMed ID: 25845917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.